Zdrowie i gospodarka · 03/08/2026

FDA Releases Revised Draft Guidance for Evaluating Skin Irritation Potential of Transdermal and Topical Delivery Systems

The US Food and Drug Administration (FDA) has made available a revised draft guidance for industry, outlining recommendations for assessing the skin irritation potential of transdermal and topical delivery systems in support of abbreviated new drug applications (ANDAs)